Dermal

The following primary dermal cells and cell models are available for use in research and drug discovery.

Human Dermal Fibroblasts (HDF)

Dermal Fibroblasts play an important regulatory role in wound repair of the skin and also in dermal inflammation. If Dermal Fibroblasts are deregulated, wound repair is often excessive and this can lead to keloids and hypertrophic scars in the skin.

Human Dermal Fibroblasts

Tissues: Breast Skin, Abdominal Skin, Foreskin

Cell Isolation: Incubate small pieces of skin with Dispase II overnight in 4°C. Separate dermis from epidermis. Incubate dermis with Liberase TM for 4 hours at 37°C. After filtration, cultivate washed cells in Fibroblasts Growth Medium at 50 000 cells/cm².

Cryopreservation: Cryopreservation of cells at P1 (or P2) in >500 000 cells/mL density.

Culture: Seed HDF at 10 000 cells/cm² in Fibroblasts Growth Medium Use cells until passage P5.

Specific Markers: P4HB and Collagen I/III

Refs:

  • Tai-Lan Tuan et al; Journal of Cell Science 1994, 107, 2285-2289.
  • Daniela Kessler-Becker et al: Biochem. J. 2004 379, 351–358.
  • Robert F. Diegelmann, Melissa C. Evans; Frontiers in Bioscience 2004, 9, 283-289.
  • Human Epidermal Keratinocytes (HEK)

    Keratinocytes produce a variety of cytokines, growth factors, interleukins and complement factors and are important for studying wound healing, inflammation, and immune response.

    human epidermal keratinocytes

    Tissues: Breast Skin, Abdominal Skin, Foreskin

    Cell Isolation: Incubate small pieces of skin with Dispase II overnight in 4°C. Separate dermis from epidermis. Incubate epidermis with trypsin/EDTA for 20 minutes at 37°C. After filtration, cultivate washed cells (Melanocytes and Keratinocytes) in Melanocytes Growth Medium at 150 000 cells/cm². Separate HEM and HEK with trypsin /EDTA. Remove the HEM and let the HEM with Keratinocytes Growth Medium.

    Cryopreservation: Cryopreservation of cells at P0-P1 in >500 000 cells/mL density.

    Culture: Use cells until passage P2 at a density of 10 000 cells/cm2 in Keratinocytes Growth Medium.

    Specific Markers: Cytokeratin 14 and Cytokeratin 1.10

    Ref:

  • J N. W. N Barker et al; Keratinocytes as initiators of inflammation; The Lancet, 1991, 337: 211-214.
  • Human Epidermal Melanocytes (HEM)

    Melanocytes produce the protective skin pigment, melanin and are located in the bottom layer of the skin’s epidermis. Changes in skin coloration often accompany inflammatory reactions and the number of melanocytes is increased in diseases such as psoriasis, lichen planus and dermatitis. Melanocytes may be useful in determining the reactivity of the skin towards external stimuli such as UV exposure and chemicals.

    human epidermal melanocytes

    Tissues: Breast Skin, Abdominal Skin, Foreskin

    Cell Isolation: Incubate small pieces of skin with Dispase II overnight in 4°C. Separate dermis from epidermis. Incubate epidermis with trypsin/EDTA for 20 minutes at 37°C. After filtration, cultivate washed cells (Melanocytes and Keratinocytes) in Melanocytes Growth Medium at 150 000 cells/cm². Separate HEM and HEK with trypsin /EDTA. Seed HEM at 106 cells/cm² in Melanocytes Growth Medium.

    Cryopreservation: Cryopreservation of cells at P2 in >500 000 cells/mL density.

    Culture: Use cells until passage P5 at a density of 10000cells/cm2 in Melanocytes Growth Medium.

    Specific Markers: Tyrosinase and Melanocyte Surface Marker

    Refs:

  • Prunieras M; International Journal of Dermatology; 1986 Volume 25, Issue 10, pages 624–628
  • Jean-Paul Ortonne, Donald L. Bissett; Journal of Investigative Dermatology Symposium Proceedings 2008, 13, 10–14.
  • Human Preadipocytes (HPAd)

    Adipose tissue is an endocrine organ involved in regulating physiologic and pathologic processes, including inflammation. It synthesizes and secretes hormones such as leptin and adiponectin as well as cytokines and chemokines, which can lead to a chronic sub-inflammatory state resulting in cardiovascular complications linked to obesity and insulin resistance. Pre-adipocytes differentiate into mature adipocytes by a complex mechanism involving several different stimuli. CellMade provides a pre-adipocyte differentiation cell model for investigating these important inflammatory processes.

    preadipocyte differentiation cell model

    Cell Differentiation Protocol: Add adipocyte differentiation medium to primary human adipocytes at 80% confluency. Allow differentiation for 10-14 days in a humidified 37°C, 5% CO2 incubator.

    Adipocyte Differentiation Medium: DMEM, d-Biotin, Insulin, DXM,IBMX, L-Thyroxine, Ciglitazone.

    Detection: OilRedO staining

    Refs:

  • F.M. Gregoire, et al; PHYSIOLOGICAL REVIEWS,1998, Vol. 78, No. 3, 783-809.
  • Barbara Antuna-Puente, et al: Therapie, 2007, 62: 4, 285-292
  • S. Nair, et al; Diabetologia. 2005; 48(9), 1784–1788
  • Human Dermal Microvascular Endothelial Cells (HDMVEC)

    Endothelial cell system for the study of angiogenesis, tumor metastasis, wound healing, inflammation, macromolecule transport and drug metabolism.

    human dermal microvascular endothelial cells

    Tissue: Foreskin

    Cell Isolation: Incubate small pieces of skin with Dispase II overnight in 4°C. Separate dermis from epidermis. Incubate dermis with Collagenase Ia for 75 minutes at 37°C. After filtration, cultivate washed cells (HDMVEC and HDF) in HDMVEC Growth Medium at 50 000 cells/cm². Detach cells with Trypsin/EDTA. Make a CD31 magnetic beads separation to isolate HDMVEC from HDF. Seed HDMVEC (CD31+) at 5000 cells/cm2 in HDMVEC Growth Medium.

    Cryopreservation: Cryopreservation of cells at P2 in >500 000 cells/mL density.

    Culture: Use cells until passage P5 at 10 000 cells/cm2 in HDMVEC Growth Medium.

    Specific Markers: CD31 and Von Willebrand Factor

    Refs:

  • Swerlick, R.A. et.al, J. Invest. Dermatol. 97(2):190 (1991)
  • Folkman, J. et al, Nature 288:551 (1980).
  • Lee, K.H. et al, J. Invest. Dermatol. 98(1):79 (1992).
  • Deryugina, E.I. et al, Hybridoma 15(4):279 (1996)
  • Sepp, N.T. et al, J. Invest. Dermatol. 104(2):277 (1995).
  • Swerlick, R.A. et al, J. Invest. Dermatol. 100(1):111S (1993).
  • Hanasaki, K. et al, J. Bio. Chem. 270(13):7533 (1995)
  • Pruckler, J.M. et al, Pathobiology 61:283 (1993)
  • Request information and pricing

    Your name*
    Your email*
    *required